C4 Therapeutics Doses First Patient In Phase 2 MOMENTUM Trial Of Oral Cemsidomide With Dexamethasone For Relapsed Refractory Multiple Myeloma
Benzinga Newsdesk 8 months ago
News
Enrollment for Phase 2 MOMENTUM Trial Expected to Be Completed in Q1 2027 Phase 1b Trial of Cemsidomide in Combination with Elranatamab on Track to Initiate in Q2 2026
Enrollment for Phase 2 MOMENTUM Trial Expected to Be Completed in Q1 2027
Phase 1b Trial of Cemsidomide in Combination with Elranatamab on Track to Initiate in Q2 2026